Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT


Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1392

PDF Downloaded: 467


Efficacy of orally disintegrating film vs intravenous ondansetron in preventing postoperative nausea and vomiting in middle ear surgeries under general anaesthesia


Full Text PDF


Original Article

Author Details : Shilpa Acharya, Kavita Adate*

Volume : 5, Issue : 4, Year : 2018

Article Page : 538-542

https://doi.org/10.18231/2394-4994.2018.0102



Suggest article by email

Get Permission

Abstract

Introduction: Ondansetron is widely used perioperative antiemetic. In this study, we have assessed the anti-emetic efficacy of orally disintegrating film (ODF) in middle ear surgeries, associated with higher incidence of PONV.
Materials and Methods: We studied two doses of ODF (4 and 8 mg) and compared it with IV ondansetron and placebo. All 120 cases were done under general anesthesia with standard anesthesia technique.
Results: Oral intake was significantly delayed in placebo group. (p= 0.001) During first 6hrs, the PONV score was significantly low (p<0> Conclusion: We conclude that all patients undergoing surgeries of middle ear should receive prophylactic antiemetic. Ondansetron in the form of orally disintegrating film is an effective as well as safe choice for PONV prevention in middle ear surgery with 8 mg to be the desired dose as compared to placebo and IV ondansetron.

Keywords: Postoperative nausea vomiting, Ondansetron, Orally disintegrating film, Middle ear surgery.



How to cite : Acharya S, Adate K, Efficacy of orally disintegrating film vs intravenous ondansetron in preventing postoperative nausea and vomiting in middle ear surgeries under general anaesthesia. Indian J Clin Anaesth 2018;5(4):538-542


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.